DEF: Hercules Capital Seeks Stockholder Approval for Below-NAV Share Issuance, Executive Compensation and Director Elections on the Agenda

Sentiment:

Proxy Statement


Hercules Capital is asking stockholders to vote on key proposals at its annual meeting, including the election of directors, executive compensation, and authorization to sell shares below net asset value (NAV).

Capital raiseHercules Capital is seeking stockholder approval to sell or issue Shares, in one or multiple public or private offerings, at a purchase price below the then-current NAV during the 12-month period expiring on the anniversary of the Annual Meeting, subject to the conditions and stockholder protections described herein.The number of Shares sold or issued in Below-NAV Sale may not exceed 25% of the number of thencurrent outstanding Shares.The purchase price of each Share sold in a Below-NAV Sale may not be more than 25% below the then-current NAV per Share.
Better than expectedThe company's performance relative to its peer group was generally at or above the 90th percentile, and in most cases at the 100th percentile, measured using ROAA, ROE and AASR.

Summary

  • Hercules Capital is holding its annual meeting of stockholders on June 18, 2025.
  • Stockholders are being asked to vote on four proposals: the election of three directors, an advisory vote on executive compensation, authorization to sell shares below NAV, and ratification of the selection of the independent public accountant.
  • The board recommends voting FOR all proposals.
  • The company is seeking authorization to sell shares below NAV under certain conditions, including a limit of 25% of outstanding shares and a price no more than 25% below NAV.
  • The company believes this flexibility is important to access capital markets, improve financial resources, and take advantage of investment opportunities.
  • The board emphasizes that this authorization does not obligate the company to conduct any below-NAV sales.
  • The proxy statement also includes information on executive compensation, director qualifications, corporate governance practices, and other important matters.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting strong performance and strategic initiatives. However, it also acknowledges the risk of dilution and regulatory limitations.

Positives

  • The company's investment platform has reached and surpassed $20 billion in cumulative debt commitments since inception.
  • The advisory vote on executive compensation received 90.3% stockholder approval in 2024.
  • The company's performance relative to its peer group was generally at or above the 90th percentile, and in most cases at the 100th percentile, measured using ROAA, ROE and AASR.
  • The company has a clawback policy for Section 16 officers.
  • The company maintains stock ownership guidelines for executive officers and directors.

Negatives

  • Stockholders face the risk of dilution if the company sells shares below NAV and they do not participate in the offering.
  • The company is subject to regulatory limitations on compensation due to its status as a BDC.

Risks

  • Stockholders face the risk of dilution if the company sells shares below NAV and they do not participate in the offering.
  • The company is subject to regulatory limitations on compensation due to its status as a BDC.
  • Market volatility could cause the valuation of a portfolio company to decline, the Company to sustain unrealized losses with respect to that portfolio company and stockholder equity to decrease in proportion to the Company's outstanding debt.

Future Outlook

The Board and the entire Hercules team remain steadfast in our efforts to maximize total stockholder returns and expand our platform capabilities for the benefit of our clients.

Management Comments

  • We are grateful to continue to serve our stockholders by successfully supporting innovative technology and life sciences companies.
  • Serving our stockholders means protecting their investment.
  • The Board of Directors and I continue to believe strongly that having this approval is protective to stockholders during times of market volatility.
  • We will continue to be guided by our unwavering commitment to venture and growthstage companies and doing what we believe is in the best interests of our stockholders just as we have done for more than 20 years.

Industry Context

The company operates in the specialty finance industry, providing senior secured loans to high-growth, innovative venture capital-backed and institutional-backed companies in technology and life sciences.

Comparison to Industry Standards

  • The Compensation Committee analyzes a peer group of internally managed BDCs, financial services companies and real estate investments trusts, or REITs.
  • As of December 31, 2024, the Company generally outperformed most of its Peer Group over the one-, threeand five-years as follows: Return on Average Assets (ROAA), Return on Equity (ROE) and Average Annual Shareholder Return (AASR).
  • Peer Group includes: Capital Southwest, Main Street Capital, Trinity Capital, AllianceBernstein, Artisan Partners, Cohen & Steers, HA Sustainable, Moelis & Company, Victory Capital, WisdomTree, Arbor Realty, Chimera Investment, EPR Properties, Essential Properties, Ladder Capital, LXP Industrial, MFA Financial, New York Mortgage, Redwood Trust, Sabra Health Care and Two Harbors.

Stakeholder Impact

  • Stockholders are impacted by the proposals, particularly the potential for dilution from below-NAV sales.
  • Employees are impacted by the executive compensation program and the company's overall performance.
  • The company's portfolio companies benefit from the company's ability to access capital and provide financing.

Next Steps

  • Stockholders are encouraged to vote on the proposals before the annual meeting on June 18, 2025.
  • The company will announce preliminary voting results at the annual meeting and file final results with the SEC.

Key Dates

DateDescription
2020-01-01Start date for equity awards in summary compensation table
2020-12-31End date for equity awards in summary compensation table
2021-01-01Start date for equity awards in summary compensation table
2021-12-31End date for equity awards in summary compensation table
2022-01-01Start date for equity awards in summary compensation table
2022-03-31End of quarter
2022-06-03End of quarter
2022-07-01End of quarter
2022-09-03End of quarter
2022-10-01End of quarter
2022-12-31End date for equity awards in summary compensation table
2023-01-01Start date for equity awards in summary compensation table
2023-03-31End of quarter
2023-06-03End of quarter
2023-07-01End of quarter
2023-09-03End of quarter
2023-10-01End of quarter
2023-12-31End date for equity awards in summary compensation table
2024-01-01Start date for equity awards in summary compensation table
2024-03-31End of quarter
2024-04-17Date of beneficial ownership determination
2024-06-03End of quarter
2024-07-01End of quarter
2024-09-03End of quarter
2024-10-02Effective date of Compensation Recoupment (Clawback) Policy
2024-10-01End of quarter
2024-12-05Date of RSU and RSMA grants
2024-12-31End date for equity awards in summary compensation table
2025-01-01Start date for equity awards in summary compensation table
2025-01-09Date of RSA grants
2025-03-31End of quarter
2025-04-17Record Date
2025-04-24Mailing of Proxy Statement
2025-06-18Annual Meeting Date
2025-08-15Expiration of current approval to sell shares of common stock if the price per share is less than the net asset value per share
2025-11-25Earliest date for submission of stockholder proposals for the 2026 annual meeting
2025-12-25Latest date for submission of stockholder proposals for the 2026 annual meeting
2026-06-18Date of 2026 annual meeting

Keywords

below NAV, executive compensation, director elections, proxy statement, annual meeting, stockholder vote, Hercules Capital, BDC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.